novo semaglutide Nordisk launches Wegovy subscription for GLP-1 obesity drugs Novo's Ozempic wins FDA nod

Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC phases one and three repeat multi-country cross-sectional surveys

Y.PereiraL.BartelinkI

Rapid weight loss without resistance training can lead to muscle loss

Blood test to measure methylmalonic acid level

This imbalance damages cellular structures, including DNA, proteins, and lipids, accelerating aging and increasing susceptibility to chronic diseases

In future studies, more gradual dose escalations over a longer escalation phase and treatment duration may help to mitigate the occurrence of dose-related GI AEs